Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever

doi:10.1084/jem.175.5.1207

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Negussie, Y.
	Articles by Griffin, G. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Negussie, Y.
	Articles by Griffin, G. E.


Social Bookmarking

	What's this?

ARTICLES

Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever

Y Negussie, DG Remick, LE DeForge, SL Kunkel, A Eynon and GE Griffin
Division of Communicable Diseases, St. George's Hospital Medical School, London, United Kingdom.

The Jarisch-Herxheimer Reaction (J-HR) is a clinical syndrome occurring soon after the first adequate dose of an antimicrobial drug to treat infectious diseases such as Lyme disease, syphilis, and relapsing fever. Previous attempts to identify factors mediating this reaction, that may cause death, have been unsuccessful. We conducted a prospective trial in Addis Ababa, Ethiopia on 17 patients treated with penicillin for proven louse-borne relapsing fever due to Borrelia recurrentis to evaluate the association of symptoms with plasma levels of tumor necrosis factor (TNF), interleukins 6, and 8 (IL-6 and -8). 14 of the 17 (82%) patients experienced a typical J-HR consisting of rigors, a rise in body temperature (1.06 +/- 0.2 degrees C) peaking at 2 h, leukopenia (7.4 +/- 0.6 x 10(-3) cells/mm3) at 4 h, a slight decrease, and then rise of mean arterial blood pressure. Spirochetes were cleared from blood in 5 +/- 1 h after penicillin. There were no fatalities, but constitutional symptoms were severe during J-HR. Plasma TNF, IL-6, and -8 were raised in several patients on admission, but a seven-, six-, and fourfold elevation of these plasma cytokine concentrations over admission levels was detected, respectively, occurring in transient form coincidental with observed pathophysiological changes of J-HR. Elevated plasma cytokine levels were not detected in the three patients who did not suffer J-HR. We conclude that the severe pathophysiological changes characterizing the J-HR occurring on penicillin treatment of louse-borne relapsing fever are closely associated with transient elevation of plasma TNF, IL-6, and -8 concentrations.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Gelderblom, H., Schmidt, J., Londono, D., Bai, Y., Quandt, J., Hornung, R., Marques, A., Martin, R., Cadavid, D. (2007). Role of Interleukin 10 during Persistent Infection with the Relapsing Fever Spirochete Borrelia turicatae. Am. J. Pathol. 170: 251-262 [Abstract] [Full Text]
Hasin, T., Davidovitch, N., Cohen, R., Dagan, T., Romem, A., Orr, N., Klement, E., Lubezky, N., Kayouf, R., Sela, T., Keller, N., Derazne, E., Halperin, T., Yavzori, M., Grotto, I., Cohen, D. (2006). Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever.. NEJM 355: 148-155 [Abstract] [Full Text]
Clark, I. A., Alleva, L. M., Mills, A. C., Cowden, W. B. (2004). Pathogenesis of Malaria and Clinically Similar Conditions. Clin. Microbiol. Rev. 17: 509-539 [Abstract] [Full Text]
Udalova, I. A., Vidal, V., Scragg, I. G., Kwiatkowski, D. (2000). Direct Evidence for Involvement of NF-kappa B in Transcriptional Activation of Tumor Necrosis Factor by a Spirochetal Lipoprotein. Infect. Immun. 68: 5447-5449 [Abstract] [Full Text]
Scragg, I. G., Kwiatkowski, D., Vidal, V., Reason, A., Paxton, T., Panico, M., Dell, A., Morris, H. (2000). Structural Characterization of the Inflammatory Moiety of a Variable Major Lipoprotein of Borrelia recurrentis. J. Biol. Chem. 275: 937-941 [Abstract] [Full Text]
Lien, E., Sellati, T. J., Yoshimura, A., Flo, T. H., Rawadi, G., Finberg, R. W., Carroll, J. D., Espevik, T., Ingalls, R. R., Radolf, J. D., Golenbock, D. T. (1999). Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products. J. Biol. Chem. 274: 33419-33425 [Abstract] [Full Text]
Winkler, U., Jensen, M., Manzke, O., Schulz, H., Diehl, V., Engert, A. (1999). Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8). Blood 94: 2217-2224 [Abstract] [Full Text]
Franz, A. R., Steinbach, G., Kron, M., Pohlandt, F. (1999). Reduction of Unnecessary Antibiotic Therapy in Newborn Infants Using Interleukin-8 and C-Reactive Protein as Markers of Bacterial Infections. Pediatrics 104: 447-453 [Abstract] [Full Text]
Fekade, D., Knox, K., Hussein, K., Melka, A., Lalloo, D. G., Coxon, R. E., Warrell, D. A. (1996). Prevention of Jarisch-Herxheimer Reactions by Treatment with Antibodies against Tumor Necrosis Factor {alpha}. NEJM 335: 311-315 [Abstract] [Full Text]
Mock, C.N., Jurkovich, G.J., Dries, D., Maier, R.V. (1996). The clinical significance of endotoxin released by antibiotics: what is the evidence?. Innate Immunity 3: 253-259 [Abstract]
Spach, D. H., Liles, W. C., Campbell, G. L., Quick, R. E., Anderson, D. E., Fritsche, T. R. (1993). Tick-Borne Diseases in the United States. NEJM 329: 936-947 [Full Text]